Sotera Health Q3 revenue beats estimates on pricing and volume
Overview
US sterilization services provider's Q3 revenue rose 4.4% yr/yr, beating analyst expectations
Adjusted EPS for Q3 increased 12%, beating analyst expectations
Company reaffirmed full-year 2026 revenue and adjusted EBITDA growth outlook
Outlook
Sotera Health sees 2026 net revenues at $1.233 bln to $1.250 bln, up 5.25%-6.75%
Company expects 2026 adjusted EBITDA of $632 mln to $641 mln, up 5.75%-7.25%
Sotera Health maintains 2026 adjusted EPS outlook at $0.95 to $1.01
Result Drivers
PRICING AND VOLUME - Co said Q3 revenue growth was driven by higher pricing, improved volume and mix, and foreign currency benefit
HARVEST TIMING - Co said Nordion segment revenue declined due to expected timing of Cobalt-60 harvest schedules
PRODUCTIVITY AND PRICING - Segment income margin benefited from operational productivity and favorable pricing, partially offset by inflation
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Beat | $324.89 mln | $319.77 mln (10 Analysts) |
Q3 Adjusted EPS | Beat | $0.29 | $0.27 (10 Analysts) |
Q3 Net Income | $58.39 mln | ||
Q3 Pretax Profit | Miss | $83.73 mln | $101.37 mln (8 Analysts) |
Q3 Gross Profit | $180.79 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Sotera Health Company is $23.25, about 31.1% above its November 2 closing price of $17.74
The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 18 three months ago
Reuters Recommended Reads
Nov 2 - IDEXX Laboratories Q3 revenue beats estimates, lifts FY profit outlook
Nov 3 - Stevanato Group Q3 revenue beats estimates on biopharma segment
Nov 3 - Revvity Q3 revenue beats estimates, raises FY guidance
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)